Body Mass Index and Outcomes in Patients Who Receive Adjuvant Chemotherapy for Colon Cancer
Top Cited Papers
Open Access
- 15 November 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 98 (22) , 1647-1654
- https://doi.org/10.1093/jnci/djj442
Abstract
Background: Although several studies have established a link between obesity and colon cancer risk, little is known about the effect of obesity on outcomes after diagnosis. We investigated the association of body mass index (BMI) with outcomes after colon cancer in patients from cooperative group clinical trials. Methods: The study cohort consisted of 4288 patients with Dukes B and C colon cancer who were accrued from July 1989 to February 1994 to National Surgical Adjuvant Breast and Bowel Project randomized trials. Risk of recurrence, second primary cancer, and mortality (overall and by likely cause) were evaluated in relation to BMI at diagnosis using statistical modeling. Median follow-up time was 11.2 years. All statistical tests were two-sided. Results: Very obese patients (BMI ≥ 35 kg/m 2 ) had greater risk of a colon cancer event (recurrence or secondary primary tumor; hazard ratio [HR] = 1.38, 95% confidence interval [CI] = 1.10 to 1.73) than normal weight patients (BMI = 18.5–24.9 kg/m 2 ). Mortality was greater for very obese (HR = 1.28, 95% CI = 1.04 to 1.57) and underweight (BMI < 18.5 kg/m 2 ) (HR = 1.49, 95% CI = 1.17 to 1.91) than for normal weight patients. The increased risk of mortality for underweight patients was dominated by non–colon cancer deaths (HR of such deaths compared with normal weight patients = 2.23, 95% CI = 1.50 to 3.31), whereas for the very obese, deaths likely due to colon cancer were increased (HR = 1.36, 95% CI = 1.06 to 1.73). Conclusions: Among colon cancer patients, a BMI greater than 35.0 kg/m 2 at diagnosis was associated with an increased risk for recurrence of and death from colon cancer. Further studies are needed to determine pathways between obesity and recurrence risk and whether weight reduction or related interventions would improve prognosis.Keywords
This publication has 32 references indexed in Scilit:
- Effect of physical activity and body size on survival after diagnosis with colorectal cancerGut, 2006
- Influence of body mass index on outcomes and treatment‐related toxicity in patients with colon carcinomaCancer, 2003
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Prevalence and Trends in Obesity Among US Adults, 1999-2000JAMA, 2002
- Clinical Trial to Assess the Relative Efficacy of Fluorouracil and Leucovorin, Fluorouracil and Levamisole, and Fluorouracil, Leucovorin, and Levamisole in Patients With Dukes' B and C Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project C-04Journal of Clinical Oncology, 1999
- Adjuvant 5-Fluorouracil and Leucovorin With or Without Interferon Alfa-2a in Colon Carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol C-05JNCI Journal of the National Cancer Institute, 1998
- Leisure-Time Physical Activity, Body Size, and Colon Cancer in WomenJNCI Journal of the National Cancer Institute, 1997
- Physical Activity, Obesity, and Risk for Colon Cancer and Adenoma in MenAnnals of Internal Medicine, 1995
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- Cholesterol, weight, height, quetelet's index, and colon cancer recurrenceJournal of Surgical Oncology, 1984